Nuveen Asset Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $4.18M | Sell |
234,426
-35,329
| -13% | -$630K | ﹤0.01% | 2065 |
|
|
2024
Q3 | $5.91M | Sell |
269,755
-6,937
| -3% | -$152K | ﹤0.01% | 1910 |
|
|
2024
Q2 | $2.16M | Sell |
276,692
-93,233
| -25% | -$727K | ﹤0.01% | 2350 |
|
|
2024
Q1 | $1.53M | Sell |
369,925
-195,699
| -35% | -$810K | ﹤0.01% | 2518 |
|
|
2023
Q4 | $1.48M | Buy |
565,624
+175,877
| +45% | +$459K | ﹤0.01% | 2552 |
|
|
2023
Q3 | $729K | Hold |
389,747
| – | – | ﹤0.01% | 2703 |
|
|
2023
Q2 | $978K | Buy |
+389,747
| New | +$978K | ﹤0.01% | 2664 |
|
|
2022
Q2 | – | Sell |
-54,748
| Closed | -$178K | – | 3381 |
|
|
2022
Q1 | $178K | Sell |
54,748
-11,295
| -17% | -$36.7K | ﹤0.01% | 3207 |
|
|
2021
Q4 | $303K | Sell |
66,043
-8,876
| -12% | -$40.7K | ﹤0.01% | 3176 |
|
|
2021
Q3 | $478K | Buy |
74,919
+27,422
| +58% | +$175K | ﹤0.01% | 3175 |
|
|
2021
Q2 | $354K | Buy |
+47,497
| New | +$354K | ﹤0.01% | 3205 |
|